# Drug Use Investigation for AVOLVE(BPH)

> **NCT01376284** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1000 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Dutasteride

## Key facts

- **NCT ID:** NCT01376284
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2013-10
- **Final completion:** 2014-06
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2014-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376284, "Drug Use Investigation for AVOLVE(BPH)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01376284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*